Factors influencing patient's perception of long-term treatment with low-molecular-weight heparins for cancer-associated thrombosis: an updated analysis of TROPIQUE, a prospective observational study

被引:4
|
作者
Debourdeau, P. [1 ]
Arvers, P. [2 ]
Hij, A. [3 ,4 ,5 ]
Bennani, H. [6 ]
Desauw, C. [7 ]
Falvo, N. [8 ]
Ghiringhelli, F. [9 ]
Hamade, A. [10 ]
Vedrine, L. [11 ]
Farge, D. [3 ,4 ,5 ]
机构
[1] Inst St Catherine, Unite Soins Support, 250 Chemin Baigne Pieds CS 80005, F-84918 Avignon, France
[2] Univ Grenoble Alpes, Lab Interuniv Psychol, BP 47, F-38040 Grenoble 9, France
[3] Hop St Louis, AP HP, Unite Med Interne Malad Autoimmunes & Pathol Vasc, 1 Ave Claude Vellefawc, F-75010 Paris, France
[4] Univ Paris 07, Paris, France
[5] Grp Francophone Thrombose & Canc, Paris, France
[6] Hop Rene Huguenin, Inst Curie, 35 Rue Daily, F-92210 St Cloud, France
[7] Hop Claude Huriez, Serv Oncol, Rue Michel Polonowski, F-59037 Lille, France
[8] Hop Bocage, Serv Med Interne, 2 Blvd Marechal Lattre Tassigny, F-21000 Dijon, France
[9] Ctr Anti Cancereux Ctr GF Leclerc, 1 Rue Prof Mar, F-21000 Dijon, France
[10] Hop Emile Muller, Unite Pathol Vasc, 20 Rue Docteur Laennec, F-68070 Mulhouse 10, France
[11] Hop Amer Paris, Serv Doncol, 63 Blvd Victor Hugo, F-92200 Neuilly Sur Seine, France
关键词
LMWH; Acceptability; Cancer; Experience; Quality of life; Venous thromboembolism; VENOUS THROMBOEMBOLISM PROPHYLAXIS; CLINICAL-PRACTICE GUIDELINES; ANTICOAGULATION THERAPY; ATRIAL-FIBRILLATION; PALLIATIVE CARE; GUIDANCE; PREVENTION; ADHERENCE;
D O I
10.1007/s00520-019-04815-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Our objective was to compare patient's expectations to their experience and to identify factors predictive of patient's perception of long-term LMWH for the treatment of cancer-associated thrombosis (CAT). Methods Results from the validated Perception Anticoagulant Treatment Questionnaires (PACTQ) completed before inclusion (PACTQ1 for expectations) and at the end (PACTQ2 for convenience and satisfaction) of the 6-month TROPIQUE study were studied with principal component analysis. Possible predictive factors of improved perception of LMWH treatment were analyzed with the Kruskall-Wallis test. Results Among 409 included patients treated with LMWH, 269 PACT-Q1 and 139 PACT-Q2 were evaluable for treatment perception. Patients had high expectations (A1-A7 score of 26.7 +/- 3.5, max = 35). Treatment cost (A7 = 1.90 +/- 1.31) and concern about a mistake in anticoagulation (A5 = 1.93 +/- 1.12) had little importance while LMWH treatment was considered easy to use (A4 = 4.20 +/- 0.93). Six-month treatment with LMWH was associated with a high rate of convenience (B1-B11, C1-C2 = 55.1 +/- 8.38, max = 65) and a high satisfaction score (D1-D7 = 25.1 +/- 4.32, max = 35). Patients' confidence in treatment and perception of possible LMWH side effects were moderate while perception of autonomy and independence significantly improved at the end of the study compared to inclusion. PACT-Q2 satisfaction score was low in patients who experienced bleeding (PACT-Q2 24.1 +/- 3.3 vs. 25.1 +/- 4.3). LMWH twice daily tended to be found less convenient compared than once daily (53.3 +/- 7.2 vs. 55.0 +/- 8.3). Conclusion CAT patients had a good perception of the 6-month LMWH treatment when comparing expectations and experience. Using a quantitative scale validated in the general population for VTE and subcutaneous injection and including a large number of patients, bleeding complications and LMWH twice daily were associated with a nonsignificant trend towards a worsen perception.
引用
收藏
页码:287 / 293
页数:7
相关论文
共 50 条